Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?

Background: Upfront cytoreductive nephrectomy (CN) is no longer the standard of care for patients with metastastic renal cell carcinoma (mRCC) with intermediate or poor prognosis according to the International mRCC Database Consortium categories. Objective: To investigate indications for CN followin...

Повний опис

Бібліографічні деталі

Автори:	Elisabeth E. Fransen van de Putte, Luna van den Brink, Mohamed A. Mansour, Johannes C. van der Mijn, Sofie Wilgenhof, Johannes V. van Thienen, John B.A.G. Haanen, Ekaterini Boleti, Thomas Powles, Patricia J. Zondervan, Niels M. Graafland, Axel Bex
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2023-09-01
Серія:	European Urology Open Science
Предмети:	Cytoreductive Ipilimumab Nephrectomy Nivolumab Indications
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S2666168323003798
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!